JP2011520977A5 - - Google Patents

Download PDF

Info

Publication number
JP2011520977A5
JP2011520977A5 JP2011510691A JP2011510691A JP2011520977A5 JP 2011520977 A5 JP2011520977 A5 JP 2011520977A5 JP 2011510691 A JP2011510691 A JP 2011510691A JP 2011510691 A JP2011510691 A JP 2011510691A JP 2011520977 A5 JP2011520977 A5 JP 2011520977A5
Authority
JP
Japan
Prior art keywords
composition
pharmaceutically acceptable
solvate
compound
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011510691A
Other languages
English (en)
Japanese (ja)
Other versions
JP5757864B2 (ja
JP2011520977A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/044743 external-priority patent/WO2009143295A1/en
Publication of JP2011520977A publication Critical patent/JP2011520977A/ja
Publication of JP2011520977A5 publication Critical patent/JP2011520977A5/ja
Application granted granted Critical
Publication of JP5757864B2 publication Critical patent/JP5757864B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011510691A 2008-05-20 2009-05-20 水溶性アセトアミノフェン類似体 Expired - Fee Related JP5757864B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5477408P 2008-05-20 2008-05-20
US61/054,774 2008-05-20
PCT/US2009/044743 WO2009143295A1 (en) 2008-05-20 2009-05-20 Water-soluble acetaminophen analogs

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014049672A Division JP2014111658A (ja) 2008-05-20 2014-03-13 水溶性アセトアミノフェン類似体

Publications (3)

Publication Number Publication Date
JP2011520977A JP2011520977A (ja) 2011-07-21
JP2011520977A5 true JP2011520977A5 (enExample) 2012-07-05
JP5757864B2 JP5757864B2 (ja) 2015-08-05

Family

ID=41340538

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2011510691A Expired - Fee Related JP5757864B2 (ja) 2008-05-20 2009-05-20 水溶性アセトアミノフェン類似体
JP2014049672A Withdrawn JP2014111658A (ja) 2008-05-20 2014-03-13 水溶性アセトアミノフェン類似体
JP2016016971A Expired - Fee Related JP6063072B2 (ja) 2008-05-20 2016-02-01 水溶性アセトアミノフェン類似体
JP2016242968A Withdrawn JP2017057217A (ja) 2008-05-20 2016-12-15 水溶性アセトアミノフェン類似体
JP2018098716A Withdrawn JP2018135392A (ja) 2008-05-20 2018-05-23 水溶性アセトアミノフェン類似体
JP2020074690A Withdrawn JP2020114876A (ja) 2008-05-20 2020-04-20 水溶性アセトアミノフェン類似体

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2014049672A Withdrawn JP2014111658A (ja) 2008-05-20 2014-03-13 水溶性アセトアミノフェン類似体
JP2016016971A Expired - Fee Related JP6063072B2 (ja) 2008-05-20 2016-02-01 水溶性アセトアミノフェン類似体
JP2016242968A Withdrawn JP2017057217A (ja) 2008-05-20 2016-12-15 水溶性アセトアミノフェン類似体
JP2018098716A Withdrawn JP2018135392A (ja) 2008-05-20 2018-05-23 水溶性アセトアミノフェン類似体
JP2020074690A Withdrawn JP2020114876A (ja) 2008-05-20 2020-04-20 水溶性アセトアミノフェン類似体

Country Status (12)

Country Link
US (4) US20110212926A1 (enExample)
EP (1) EP2291348A4 (enExample)
JP (6) JP5757864B2 (enExample)
KR (1) KR101698028B1 (enExample)
CN (2) CN105254662A (enExample)
AU (1) AU2009249067A1 (enExample)
BR (1) BRPI0912326A2 (enExample)
CA (1) CA2724877C (enExample)
IL (1) IL209382A0 (enExample)
MX (1) MX2010012648A (enExample)
RU (1) RU2010151952A (enExample)
WO (1) WO2009143295A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0912820A2 (pt) 2008-05-20 2015-10-13 Neurogesx Inc pró-fármacos de relação hepatoprotetora de acetaminofeno
KR101677126B1 (ko) * 2008-05-20 2016-11-22 노이로제스엑스, 인코포레이티드 탄산염 프로드러그 및 그것의 사용 방법
JP5757864B2 (ja) 2008-05-20 2015-08-05 ニューロジェシックス， インコーポレイテッド 水溶性アセトアミノフェン類似体
EP2177215A1 (en) 2008-10-17 2010-04-21 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of tramadol and NSAIDs
US9359376B2 (en) * 2011-04-08 2016-06-07 Sphaera Pharma Pte. Ltd Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds
AU2012312136B2 (en) 2011-09-22 2017-06-29 Acorda Therapeutics, Inc. Acetaminophen conjugates, compositions and methods of use thereof
AU2014306759B2 (en) 2013-08-12 2018-04-26 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
EP3169315B1 (en) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
CN117164657A (zh) 2014-08-12 2023-12-05 莫纳什大学 定向淋巴的前药
US20160106737A1 (en) 2014-10-20 2016-04-21 Pharmaceutical Manufacturing Research Services, Inc. Extended Release Abuse Deterrent Liquid Fill Dosage Form
MX393568B (es) 2014-10-21 2025-03-24 Abbvie Inc Profarmacos de carbidopa y l-dopa y metodos de uso
CA3013751C (en) 2015-03-03 2023-08-08 Kindred Biosciences, Inc. Compositions and methods for treatment and prevention of pyrexia in horses
EP3347340A4 (en) 2015-09-08 2019-01-23 Monash University LYMPHENLEITUNGSPRODRUGS
JP2019515908A (ja) * 2016-04-20 2019-06-13 アッヴィ・インコーポレイテッド カルビドパ及びｌ−ドパプロドラッグ並びに使用方法
US11883497B2 (en) 2017-08-29 2024-01-30 Puretech Lyt, Inc. Lymphatic system-directing lipid prodrugs
WO2019046491A1 (en) 2017-08-29 2019-03-07 Ariya Therapeutics, Inc. LIPIDIC PRODRUGS DIRECTING TO THE LYMPHATIC SYSTEM
US11608345B1 (en) 2017-12-19 2023-03-21 Puretech Lyt, Inc. Lipid prodrugs of rapamycin and its analogs and uses thereof
US11304954B2 (en) 2017-12-19 2022-04-19 Puretech Lyt, Inc. Lipid prodrugs of mycophenolic acid and uses thereof
WO2019126378A1 (en) 2017-12-19 2019-06-27 Ariya Therapeutics, Inc. Lipid prodrugs of mycophenolic acid and uses thereof
EP3846852A4 (en) 2018-09-07 2022-06-15 R.P. Scherer Technologies, LLC Solid or semisolid lipid based dosage form stabilization through curing and addition of low hlb surfactant(s)
UY38473A (es) 2018-11-15 2020-06-30 Abbvie Inc Formulaciones farmacéuticas para una administración subcutánea
WO2021041800A1 (en) * 2019-08-30 2021-03-04 Remedy Diagnostics LLC Transdermal device comprising pain molecules
AU2021217172A1 (en) 2020-02-05 2022-09-22 Monash University Lipid prodrugs of neurosteroids

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2444043A1 (fr) * 1978-12-15 1980-07-11 Bottu Nouveau derive du paracetamol, son procede de preparation et son utilisation en therapeutique
DK406686D0 (da) * 1986-08-26 1986-08-26 Hans Bundgaard Carboxylsyrederivater
US5001115A (en) * 1989-05-17 1991-03-19 University Of Florida Prodrugs of biologically active hydroxyaromatic compounds
CA2072360A1 (en) * 1989-12-26 1991-06-27 Abraham J. Domb Prodrug anhydride compositions
US5627165A (en) * 1990-06-13 1997-05-06 Drug Innovation & Design, Inc. Phosphorous prodrugs and therapeutic delivery systems using same
US5272171A (en) * 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
US6750216B2 (en) * 1996-03-08 2004-06-15 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
IT1282736B1 (it) * 1996-05-21 1998-03-31 Angelini Ricerche Spa Uso di derivati del p-amminofenolo per preparare composizioni farmaceutiche utili nel trattamento di malattie neurodegenerative
CA2289969A1 (en) * 1997-05-15 1998-11-19 Drug Innovation & Design, Inc. Acyclovir diester derivatives
US5985856A (en) 1997-12-31 1999-11-16 University Of Kansas Water soluble prodrugs of secondary and tertiary amine containing drugs and methods of making thereof
PT1056754E (pt) * 1998-01-29 2004-03-31 Bristol Myers Squibb Co Derivados fosfatados de 1,3,4-oxadiazolona de diarilo
US6204257B1 (en) * 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
ATE232382T1 (de) * 1998-09-10 2003-02-15 Nycomed Danmark As Pharmazeutische zusammensetzungen mit schneller freisetzung von wirkstoffen
US8231899B2 (en) * 1998-09-10 2012-07-31 Nycomed Danmark Aps Quick release pharmaceutical compositions of drug substances
US6461631B1 (en) * 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
US6362172B2 (en) 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
HRP20020853A2 (en) * 2000-03-29 2005-02-28 Altana Pharma Ag Alkylated imidazopyridine derivatives
IL158882A0 (en) * 2001-06-05 2004-05-12 Control Delivery Sys Inc Sustained-release analgesic compounds
JP2005516987A (ja) * 2002-02-05 2005-06-09 ブリストル−マイヤーズ　スクイブ　カンパニー Ｎ−置換された３−ヒドロキシ−４−ピリジノン化合物およびそれを含む医薬
US20040058946A1 (en) * 2002-07-05 2004-03-25 Buchwald Stephen L. Abuse-resistant prodrugs of oxycodone and other pharmaceuticals
US7705045B2 (en) * 2002-11-14 2010-04-27 Syntarga, B.V. Prodrugs built as multiple self-elimination-release spacers
WO2004078180A2 (en) * 2003-03-03 2004-09-16 Guilford Pharmaceuticals Inc. Naaladase inhibitors for treating opioid tolerance
MXPA05009757A (es) * 2003-03-13 2005-12-05 Controlled Chemicals Inc Conjugados de oxicodona con menor potencial de abuso y duracion de accion extendida.
AU2003901813A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Pharmaceutical derivatives
US20050080260A1 (en) * 2003-04-22 2005-04-14 Mills Randell L. Preparation of prodrugs for selective drug delivery
US6992090B2 (en) * 2003-06-16 2006-01-31 Adolor Corporation Substituted piperidine compounds and methods of their use
US20050026879A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20070093457A1 (en) * 2004-02-11 2007-04-26 Nadir Arber Compositions for treatment of cancer and inflammation with curcumin and at least one nsaid
ES2402552T3 (es) 2004-07-06 2013-05-06 Abbott Laboratories Profármacos de inhibidores de proteasa de VIH
JP2010511717A (ja) 2006-12-05 2010-04-15 ニューロジェシックス， インコーポレイテッド プロドラッグおよびその作成ならびに使用方法
JP5757864B2 (ja) 2008-05-20 2015-08-05 ニューロジェシックス， インコーポレイテッド 水溶性アセトアミノフェン類似体
KR101677126B1 (ko) * 2008-05-20 2016-11-22 노이로제스엑스, 인코포레이티드 탄산염 프로드러그 및 그것의 사용 방법
BRPI0912820A2 (pt) 2008-05-20 2015-10-13 Neurogesx Inc pró-fármacos de relação hepatoprotetora de acetaminofeno
US8569466B2 (en) 2008-09-10 2013-10-29 Nnochiri Ekwuribe Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancers
JP2012520342A (ja) 2009-03-16 2012-09-06 ジェンメディカ・セラピューティックス・ソシエダッド・リミターダ 代謝障害を処置するのに有用な抗炎症剤および抗酸化剤のコンジュゲート
AU2012312136B2 (en) 2011-09-22 2017-06-29 Acorda Therapeutics, Inc. Acetaminophen conjugates, compositions and methods of use thereof

Similar Documents

Publication Publication Date Title
RU2010151952A (ru) Водорастворимые аналоги ацетаминофена
RU2356547C2 (ru) Способы лечения рака с использованием ингибиторов hdac
JP2011523645A5 (enExample)
CN1468111A (zh) 治疗急性、慢性疼痛和/或神经病性疼痛和偏头痛的药物组合物
AR075735A1 (es) Composiciones farmaceuticas de liberacion inmediata que comprenden oxicodona y naloxona. uso
RU2009118960A (ru) Комбинации ацетаминофена/ибуппрофена
JP2013535437A5 (enExample)
RU2010151951A (ru) Общие пролекарства гепатопротектора и ацетаминофена
JP2012533565A5 (enExample)
JP2019511529A5 (enExample)
JP2013541583A5 (enExample)
ES2649492T3 (es) (S)-pirlindol o sus sales farmacéuticamente aceptables para uso en medicina
MX2013013014A (es) Metodo para el tratamiento de tumores solidos avanzados.
JP2015229675A (ja) 膵臓癌を治療するための医薬製剤
AR078170A1 (es) Metodos para el tratamiento de tumores cerebrales
JP2026048781A (ja) インドール化合物を用いた疼痛又は間質性膀胱炎の治療方法
JP7830540B2 (ja) ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス
RU2005133665A (ru) Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств
JP2014530204A5 (enExample)
WO2018023098A1 (en) Radiolabeled ligands for targeted pet/spect imaging and methods of their use
JP2017533956A (ja) 筋肉痛を含む病態の治療のための組合せ
RU2015117483A (ru) Комбинации
ES2649491T3 (es) (R)-pirlindol y sus sales farmacéuticamente aceptables para uso en medicina
RU2013148627A (ru) Производные тиено [2, 3-d] пиримидина и их применение для лечения аритмии
JP2009504668A5 (enExample)